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The graft-vs.-host (GVH)  1 reaction produced in F1 recipients of parental lympho- 
cytes is a complex phenomenon determined by many interacting elements. The  anti- 
genic disparity between donor and host (1), the host reaction to attack by donor cells 
(2),  modulating effects of the host on donor cell reactivity  (3),  and the proportional 
representation of subpopulations of thymus-derived cells (T cells) in the donor inocu- 
lum inducing the reaction  (4) are but some of the relevant factors which have  been 
elucidated.  An additional component of the reaction has been revealed  in the recent 
studies of Uphoff (reviewed in reference 5).  She demonstrated that in lethally irradi- 
ated reciprocal hybrid FI mice reconstituted with bone marrow from parental  strains, 
a  significant survival advantage was conferred on recipients  when the marrow donor 
strain was syngeneic with the maternal strain of the hybrid cross.  It was suggested 
that maternal modification in utero of the expression  of paternal histocompatibility 
phenotype on FI cells,  resulting in reduced antigenicity, may be  responsible for this 
phenomenon. She also proposed that this effect may serve as a partial  explanation for 
the survival of semiallogeneic  fetuses in the uterus  of a mother potentially capable of 
mounting a  homograft reaction against fetal histocompatibility antigens  of paternal 
type. 
In the current  studies  we have evaluated  the reactivity of parental  splenic 
lymphocytes against tissues from reciprocal hybrid mice in three systems: the 
mixed lymphocyte reaction  (MLR);  the Simonsen spleen weight  GVH assay; 
and a  GVH mortality assay. Our Iesults reveal no difference in the capacity of 
parental  cells to proliferate in the MLR on exposure to cells from either cross, 
but  demonstrate  marked  discrepancies  in  the  ability  of cells  from  maternal 
*Present  address:  Department  of  Surgery,  Massachusetts  General  Hospital,  Boston, 
Mass. 02114. 
i Abbr~a~ions used in this paper: cpm, counts per  minute;  GVI-I, graft-vs.-host;  MHC, 
major histocompatibility  complex; MLR, mixed lymphocyte reaction;  SEM,  standard  error 
of the mean. 
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and  paternal  strains  to  produce  mortality  or  splenomegaly  in  their  hybrid 
recipients. 
Materials and Methods 
Mice.--6- to 8-wk old male BALB/cAnN (H-2 d) and  C57BL/6N (H-2 b) mice and 1- to 
6-day old reciprocal hybrid litters of these strains (BALB/c 9  X  C57BL/6o  ~) F1 (H-2d/H-2  b, 
(BALB/c X  C57BL/6 F1)  and (C57BL/6  9  X  BALB/co  z)  Ft (H-2b/H-2 d,  (C57BL/6 X 
BALB/c)  F1)  were  obtained  from  the  Rodent  and  Rabbit  production  Section,  National 
Institutes of Health, Bethesda, Md. Mothers of all F1 litters were primiparons. 
Mixed Lymphocyte Reactions.--Spleen  cell suspensions  from adult mice were prepared and 
cultured as previously described (6). Briefly, 1 X  106 spleen cells from C57BL/6 or BALB/c 
mice were cultured with 1 X  106 spleen cells from (BALB/c X  C57BL/6) F1 or (C57BL/6 X 
BALB/c) F1 mice in 0.2  ml RPMI  1640, supplemented with 5% fetal calf serum, in  round- 
bottom microfiter wells.  Cultures were maintained in a  humidified 5% CO2 atmosphere  at 
37°C for 72 h.  16 h  after the addition of 1 De of 3H-thymidine to each well, the cells were 
harvested with a microculture harvesting device (7), modified by one of us (M. R. H.) 2 and 
the amount of radioactivity incorporated into acid precipitable material measured by  scin- 
tillation spectrometry. Results are expressed  as the mean 4- the standard error of the  mean 
(SEM) of the counts per minute  (cpm)  incorporated in four replicate cultures.  Stimulation 
was considered to have occurred when the cpm incorporated in the mixed cultures  exceeded 
the cpm incorporated in control syngeneic mixtures of the stimulator  and  responder  cells. 
Stimulator cells were not inactivated before addition to mixed cultures.  Stimulated/control 
radios (S/C) were calculated as 
2 X  (parent +  F1) cpm 
s/c  = 
(parent +  parent) cpm -[- (F1 4- F,) cpm ' 
GVIt Reactions.--CeU suspensions from spleens of adult BALB/c and C57BL/6 mice were 
prepared in Hanks's balanced salt solution by mincing with scalpels and filtration through 
triple-layered gauze. 
A modification of the Simonsen spleen-weight assay (8) was performed by administration 
of varying doses of parental spleen calls to litters of 1-4-day old F1 recipients. 9 days later, 
inoculated mice and  their littermate controls were sacrificed and  the spleen index for each 
litter  determined.  The  mean  spleen index  for  each cell dose was computed  by averaging 
the mean indices obtained from each  litter inoculated with  that  cell dose.  Spleen indices 
greater than  1.3 are considered to represent significant GVH activity (9). 
A GVH mortality assay was performed as described by Tigelaar and Asofsky (10). Briefly, 
1-6-day old F1 mice were sublethally irradiated with 400 R  1-3 h before intraperitoneal injec- 
tion with varying doses  of parental spleen cells.  Inoculated mice and uninoculated controls 
were observed for 50 days.  Since the majority of deaths in control animals (averaging 10% 
and due primarily to cannibalism) occurred during the first week, analysis of mortality between 
days 7 and 50 was used to measure GVH activity. Cumulative mortality was  calculated  as 
the percentage of dead mice at day 50 relative to the number alive on day 7. Only male mice 
were used as donor animals in both GVH assays. 
RESULTS 
MLR's.--To  determine if spleen ceils from either C57BL/6 or BALB/c  mice 
could  discriminate  between  (BALB/c  X  C57BL/6)  F1  and  (C57BL/6  X 
2 M. R. Harrison, G. B. Thurman, and G. M. Thomas. Manuscript submitted for pub!ica- 
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BALB/c) F1 target cells in vitro, MLR's were performed with all combinations 
of these  cells.  The results presented in Table I  indicate that  C57BL/6  and 
BALB/c spleen cells responded to (BALB/c X  C57BL/6) F1 and (C57BL/6 X 
BALB/c) F1 cells equally. In addition, there is no significant difference between 
(BALB/c  X  C57BL/6)  F1 and  (C57BL/6  X  BALB/c)  Ft  cells in  their ca- 
pacity to stimulate cells of either parental strain in the MLR. 
Spleen-Weight GVH Assays.--The in vivo reactivity of C57BL/6 and BALB/c 
spleen cells in (C57BL/6 X  BALB/c) FI and (BALB/c  X  C57BL/6)  F1  re- 
cipients as measured by the Simonsen spleen-weight GVH assay is shown in 
Fig.  1. The two top panels indicate the dose-response curves obtained on in- 
jection of parental cells from both strains into either (C57BL/6)K BALB/c) F1 
(Fig. 1, a) or (BALB/c X  C57BL/6) (Fig. 1, b) recipients. In agreement with 
the MLR studies, the reactivity of spleen cells from each parental line in either 
hybrid cross was essentially equivalent.  In the two lower panels,  this data has 
been replotted to show comparisons of the activity of cells from one parental, 
C57BL/6 (Fig. 1, c) or BALB/c (Fig. 1, d), with both F1 recipients. Contrary to 
the predictions of the MLR's, greater splenomegaly was observed at all cell doses 
tested in (BALB/c X  C57BL/6) F1 than (C57BL/6 X  BALB/c) F1, regardless 
of the grafted parental strain. 
Mortality GVH Assays.--The GVH reactivity of parental spleen cells in  the 
reciprocal hybrids was also assessed in the mortality assay (Fig.  2). The top 
three panels of this figure indicate the cumulative mortality over time resulting 
from inoculation of (BALB/c X  C57BL/6) F1 or (C57BL/6  X  BALB/c) F1 
recipients with 2.5  X  10  e, 5 X  106, or 10 X  106 BALB/c spleen cells. The lower 
three panels present the cumulative mortality over time observed following in- 
TABLE I 
Stimulatory Capacity of Reciprocal Hybrid (BALB/c  X  C57BL/6)  Ft and  (C57BL/6 X 
BALB/c) F1 Spleen Cells in the MLR 
Spleen cell  mixture* 
[SH]Thymidine  incorporation 
(Mean :1: SEM)  S/C$ 
C57BL/6 -t- C57BL/6 
C57BL/6 -]- (C57BL/6 X BALB/c) F1 
C57BL/6 -[- (BALB/c X C57BL/6) Ft 
BALB/c -t- BALB/c 
BALB/c +  (C57BL/6 X BALB/c) F1 
BALB/c +  (BALB/c X C57BL/6) F1 
(C57BL/6 X BALB/c) F1 +  (C57BL/6 X BALB/c) F1 
(BALB/c X C57BL/6) F1 +  (BALB/c X C57BL/6) F1 
3,582  4- 450 
8,994 ±  368 
9,056  4-  524 
6,449 -4- 407 
12,059 -4- 658 
11,982 -4-  1072 
1,449 -4- 89 
1,394 -4-  191 
3.57 
3.64 
3.05 
3.06 
* See Materials and Methods for details of conditions. 
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FIG. 1.  Simonsen spleen-weight assay of the graft-vs.-host reactivity of spleen cells from 
BALB/c  and C57BL/6 donors in  (CS7BL/6 X  BALB/c)  F1 and (BALB/c  X  C57BL/6) 
Fx hosts. Each point represents the mean spleen index obtained from 6-22 recipient litters. 
Vertical bars indicate the limits of 1 SEM. (See text for further details.) 
oculation of these F1 mice with the same doses of C57BL/6  spleen cells. These 
results demonstrate that at spleen cell doses of 5  X  106 and 10 X  108, inocula 
of BALB/c  spleen cells produced greater mortality in (C57BL/6  X  BALB/c) 
FI than (BALB/c X  C57BL/6)  F1 mice (Fig. 1, a-c).  By comparison, mortality 
produced in the reciprocal hybrids by administration of C57BL/6  spleen cells 
is greater at each cell dose tested in (BALB/c  X  C57BL/6)  FI than (C57BL/ 
6  X  BALB/c)  F1 recipients, although the differences  are great  only at a dose 
of 2.5 X  106 cells. Both male and female mice were survivors in all assay combi- 
nations. 
To further evaluate the differing reactivities observed in these combinations, 
the percentages  of 50 day mortalities  (from Fig.  2)  were plotted on a probit 
scale as a function of numbers of cells injected, plotted on a logarithmic scale 
(Fig.  3).  The  left  hand  panel  demonstrates  the  mortality  observed  in H.  C.  MORSE~  III~  M.  R.  HARRISON~  AND  R.  ASOFSKY  725 
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Fro.  2.  Mortality  assay  of  graft-vs.-host  reactivity  of  spleen  cells  from  BALB/c  and 
C57BL/6  donors in irradiated  (C57BL/6  X  BALB/c)  F1 and  (BALB/c  X  C57BL/6)  F1 
hosts. Each line represents the cumulative mortality observed in 25-43 recipient  F1 mice in 
two experiments over a 50 day observation  period. 
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FIG. 3.  Comparisons of cumulative percent  mortality among irradiated  F1 recipients  of 
graded numbers of BALB/c and C57BL/6 spleen cells over a 50 day observation period. The 
50 day percent mortalities are plotted on a probit scale as a function of the logarithm of the 
cell inoculum. 
(C57BL/6 X  BALB/c) F1 recipients of BALB/c or C57BL/6 spleen cells while 
the right panel presents the data for (BALB/c X  C57BL/6) Fz recipients of 
parental cells. In contrast to the findings of the spleen-weight  GVH assay which 
demonstrated differential  reactivity dependent on the hybrid cross (BALB/c X 
C57BL/6) Fl's giving greater splenomegaly than (C57BL/6 X  BALB/c) Fl's, 
C57BL/6 spleen  cells are more lethal than BALB/c cells regardless  of the F1 
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The results presented in this paper can be summarized as indicated in Table 
II. The top two lines present the relative reactivities in the MLR, spleen-weight 
GVH assay, and mortality GVH assay of (BALB/c X  C57BL/6) F1, as com- 
pared  with  (C57BL/6  X  BALB/c)  F1  mice  ([BALB/c  X  C57BL/6]  F1/ 
[C57BL/6  X  BALB/c] F1), on exposure to spleen cells from either parental 
strain. The two lower lines compare the relative reactivities of parental spleen 
cells (BALB/c/C57BL/6) when presented with either (C57BL/6 X  BALB/c) 
F1 or (BALB/c X  C57BL/6) FI cells. Because reactivity curves did not form 
parallel  lines in either the spleen-weight (Fig.  1) or mortality GVH assays,  a 
more quantitative comparison  of activities in these  assays  cannot be  made. 
However, this simplified analysis does permit a useful qualitative evaluation of 
the relative reactivities observed. 
TABLE II 
Rdative Reactivities of Parental Cdls with Reciprocal Hybrid (BALB/e X  C57BL/6)  F1 and 
(C57BL/6  X  BALB/c) F1 Tissues in the Mixed Lymphocyte Reaction (MLR), 
the Simonsen Spleen-Weight Assay (SSW), and the Mortality Assay 
1 
2 
3 
4 
C57BL/6 
BALB/c 
(C57BL/6 X BALB/c) Ft 
(BALB/c X C57BL/6) FI 
MLR 
(BALB/c X C57BL/6) F~/ 
(C57BL/6 X BABL/c)Ft 
1 
1 
BALB/c/C57BL/6 
1 
1 
SSW 
(BALB/c X C57BL/6) F~/ 
(C57BL76 X BALB/c)Ft 
>1 
>1 
BALB/c/C57BL/6 
1 
1 
Mortality 
(BALB/c X C57BL/6) F# 
(C57BL/6 X BALB/c) Fx 
>1 
<1 
BALB/c/CS?BL/6 
<1 
<1 
DISCUSSION 
It  has  been  generally  accepted  that  genetically determined  phenotypic 
differences between mouse strains detected by (a) elicitation of alloantibodies 
on cross immunization, (b) stimulation in one-way MLR's, (c) rapid skin graft 
rejection, or (d) development of GVH reactions in mice incapable of responding 
to donor cells were identical and coded for by the H-2 region of the major histo- 
compatibility complex (MHC). The laws of Mendelian genetics dictate that re- 
ciprocal hybrid mice should have identical genotypes and phenotypes and would 
not predict differential capacity for cells from these crosses to stimulate parental 
cells in the MLR or for parental cells to show differential reactivity with these 
hybrids in GVH assays. In keeping with this view, our studies with reciprocal 
hybrids, (BALB/c X C57BL/6) Fl's and (C57BL/6 X  BALB/c) F,'s, revealed 
no differences between  these  strains in  their capacity to stimulate parental 
BALB/c or C57BL/5 cells in the MLR (Table I). However, the demonstration 
(Figs.  1-3, Table II) of marked discrepancies between  these hybrids in their 
responses to parental cells in the spleen-wcight and mortality GVH assays di- 
rectly challenges this dogma. H.  C.  MORSE,  lII,  M.  R.  HARRISON,  AND  R.  ASOFSKY  727 
Several possible explanations for these heretical observations of variable reac- 
tivity between reciprocal hybrids should be considered: (a) maternal modifica- 
tion of histocompatibility antigens; (b) antireceptor antibodies; (c) suppressor 
cells; and (d) enhancing antibodies. 
In studies of several pairs of reciprocal hybrid mice (5, 11-13)  lethally irradi- 
ated and inoculated with bone marrow from both parental strains, Uphoff has 
demonstrated a  significant reduction in mortality when marrow donors were 
syngeneic with the female of the hybrid cross. As late mortality in this system is 
indicative of GVH disease, her findings are completely predictive of the mor- 
tality assay data presented in Figs. 2 and 3; less mortality was observed in 
(C57BL/6 X BALB/c) F1 than (BALB/c X C57BL/6) F1 recipients of C57BL/6 
cells and BALB/c spleen cells were more lethal for (C57BL/6  X  BALB/c) F1 
than (BALB/c X  C57BL/6)  FI hosts. The mortality assay employed in the 
present study is more "purely immunologic" than the marrow transplantation 
system used by Uphoff. In her studies marrow cells serve two  functions; pro- 
tection of the irradiated host and production of GVH disease. In our system, 
cell inoculation is not required for survival of irradiated mice and essentially 
all deaths are due to GVH disease (10).  While these findings stand in sharp 
contrast to the predictions of the MLR's, it should be noted that MLR's were 
performed with mixtures of adult parental and adult F1 cells whereas both the 
spleen-weight and mortality GVH assays involve exposure of neonatal F1 tissues 
to adult parental cells. By comparison with adult tissues, neonatal cells have 
been shown to have reduced stimulatory capacity in the MLR (14). However, 
neonatal tissues of these crosses  should not differ and the differences seen be- 
tween MLR and GVH mortality are still unexpected. 
One explanation for these findings has been ofered by Uphoff (11). She sug- 
gests that reduced antigenicity of the parental phenotype on F1 cells as a result 
of maternal modifications is responsible for the differential susceptibility of F~ 
mice to GVH mortality. She has also presented data to indicate that similar 
"antigenic defects" can be inherited in that ova transplant strain RIIIeB (RIII 
strain fetuses transferred to pregnant C57BL mice with the RIIIeB line de- 
rived from the progeny) is less susceptible to mortality induced by C57BL cells 
than is the ancestral RIII strain (13). Although a mechanism for this modifica- 
tion has not been described, confirmation of its heritable nature would be ex- 
tremely important, for none of the other alterations to be discussed should be re- 
flected in the genetic makeup of host animals. 
Ramseier and Lindenmann have shown that adult F1 mice and rats multiply 
injected with lymph node cells from one parental strain produce antibodies re- 
active with the recognition structures by means of which these cells react with 
alloantigens of the other parental line (15,  16).  These "aliotypic"  antibodies 
are capable of reducing the capacity of lymphoid cells  from the immunizing 
strain to react with F1 tissues. Moreover, exposure of adult cells to such sera re- 
duced the GVH mortality produced in recipient mice as compared with that 728  GRAFT-VS.-HOST REACTIONS  IN  RECIPROCAL  HYBRID  MICE 
resulting from inoculation ot untreated cells (17)--an assay system quite similar 
to that employed in the present study. Although in our investigations  neonatal 
F1 mice were exposed to but  one  injection  of parental  cells, such  antibodies 
could have been formed, reducing the effector capacity of the donor cell inocu- 
lure. If this were the case, it would require that (BALB/c X  C57BL/6)  F~'s 
produce more antibody  than (C57BL/6 X BALB/c) Fl'S on exposure to BALB/c 
spleen cells which were considerably more lethal in the latter strain (Figs. 2 and 
3; Table II). Against this possibility are the data obtained in the Simonsen as- 
say (Fig.  1)  which demonstrates that greater splenomegaly was produced  in 
(BALB/c X C57BL/6) F1 than (C57BL/6 X BALB/c) F1 recipients of BALB/c 
spleen cells. Since this antibody should be produced only after some period of 
time,  the observation  of discrepancies  between  spleen-weight  and mortality 
assays might also be explained. 
Under certain conditions, F1 cells injected with parental lymphocytes reduce 
the splenomegaly produced in sublethally irradiated F1 hosts from that effected 
by parental cells alone (3). Sublethally irradiated recipients were also employed 
in our mortality assay, but to obtain the observed  effects (Fig.  1) one would 
have to postulate a differential capacity of the reciprocal hybrids to suppress the 
activity of parental effector cells. The data from the spleen-weight assay would 
suggest  that  (BALB/c X  C57BL/6)  Fl's were less  effective  suppressors  of 
parental cells than (C57BL/6  X  BALB/c) Fl's in that consistently greater 
splenomegaly is obtained with the former hybrid cross as hosts (Fig.  1), but 
this prediction is not supported by mortality assay data (Figs. 2 and 3). 
Finally, Hellstr6m et al. (18) have shown that "enhancing antibodies" from 
mice immune to paternal alloantigens protect F~ cells from destruction by im- 
mune maternal lymphocytes. This antibody could be formed during pregnancy 
as a result of maternal exposure to paternal antigens with subsequent trans- 
placental passage,  or could be produced by occasional maternal cells gaining 
access to the F1 fetus in utero (19). Again, such antibodies might affect the re- 
sults seen in the mortality  but not the spleen-weight GVH assays. 
The possibility should also be considered that the modifying  substances men- 
tioned above,  be  they antibodies  or the products of suppressor  cells, might 
have their effects only early or late in the GVH  reaction.  For instance,  ma- 
ternal  transferred  antibody would  have  a  relatively short  half-life,  might 
affect the spleen weight assay which is terminated 9 days after inoculation  of 
donor cells while having no effect on the 50 day mortality assay in which data 
accumulation is  initiated at  day 7.  By comparison,  maternally transferred 
cells may require a longer period  of time to produce  alloantibodies  with this 
effect becoming evident only in the long-term mortality assay. 
Recent studies have demonstrated that in both splenomegaly (4, 20, 21) and 
mortality assays (4,  10) of GVH activity, two populations of T  cells interact 
synergistically to produce increased spleen weight or death in F1 recipients  of 
parental cells. Data from this work also suggested that the effector cells pro- H.  C.  MORSE,  III,  M.  R.  HARRISON,  AND  R.  ASOFSKY  729 
ducing splenomegaly or death may be different (10). The latter study (10) was 
performed with  (C57BL/6 X  BALB/c)  F1  recipients  of BALB/c cells  and 
demonstrated that by comparison with  reactivity curves for thymocytes in 
spleen-weight and mortality assays, spleen  and peripheral  lymph node cells 
had different relative capacities to produce splenomegaly or death. The data in 
the present studies show a similar dissociation of splenomegaly and mortality. 
BALB/c spleen cells are quite effective in producing splenomegaly in (BALB/c 
X C57BL/6) F1 mice (Fig. 1) but have minimal activity in the mortality assay 
with this host line (Figs. 2 and 3). 
The studies of Livnat et al. (22) in strains of mice serologically indistinguish- 
able and known to differ only at intra-MHC  but non-//-2 loci  [BIO.A  (2R) 
and BIO.A (4R)]  are also re!evant to our investigations. They demonstrated 
that while it was possible to elicit GVH splenomegaly by inoculation of 2R 
neonates with 4R cells and that 2R cells serve as good stimulators for 4R cells 
in the MLR, skin grafts exchanged between these strains survive indefinitely, 
thus dissociating GVH effector cells from those responsible for skin graft re- 
jection. Taken together, these studies suggest that predictions for activity of 
lymphocytes in one T-cell system, e.g. spleen-weight GVH, based on their re- 
activity in another assay, e.g. mortality, may be unjustified in that  these sys- 
tems may reflect the activity of different T-cell subpopulations. However, cau- 
tion is indicated in using these data to indicate heterogeneity if any of the above 
mentioned speculations on alteration of GVH reactivity with time are true. 
It should be emphasized that the latter studies (22) were performed in mice 
with known genetic differences, this being predictive of phenotypic variation as 
well as the possibility of detecting these differences with appropriate assay sys- 
tems. The central paradox of the current investigations is that  (BALB/c X 
C57BL/6) F1 and (C57BL/6 X BALB/c) F1 mice which should be genotypically 
and phenotypically  identical vary so greatly on exposure to parental cells. While 
it is clear that no unifying explanation is currently available for our findings, it 
is also  evident that should the basis for reduced mortality of  (BALB/c  X 
C57BL/6) Ft recipients of BALB/c cells be defined, the opportunities for rou- 
tine clinical marrow transplantation could be greatly expanded. 
SUMMARY 
Spleen cells from BALB/c and C57BL/6 mice were tested for their reactivity 
against reciprocal hybrid tissues ((BALB/c X  C57BL/6) F1 and  (C57BL/6 X 
BALB/c) FI) in three assay systems: the mixed lymphocyte reaction (MLR); 
the  Simonsen  spleen-weight  graft-vs.-host  (GVH)  assay;  and  a  GVH  mor- 
tality assay. It was shown that both Fl's serve as equally effective stimulators of 
parental cells in the MLR. In the spleen-weight assay, BALB/c and C57BL/6 
cells  were equally active in a  given host, but greater splenomegaly was  ob- 
served in (BALB/c X  C57BL/6) F1 hosts regardless of the donor strain. By 
contrast, BALB/c cells were much less lethal than C57BL/6 cells in (BALB/c X 730  GRAFT-VS.-HOST  REACTIONS  IN  RECIPROCAL  HYBRID  MICE 
C57BL/6)  FI hosts  than  in  (C57BL/6  X  BALB/c)  FI hosts,  and  to  a  lesser 
degree  C57BL/6  cells  were  less  lethal  than  BALB/c  cells  in  (C57BL/6  X 
BALB/c)  F1  hosts.  The possibility  that  modifying substances  may differen- 
tially  alter  reactivity  of parental  lymphocytes and  that considerations  other 
than genotype determine the outcome of a GVH reaction are discussed in detail. 
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